New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies

Migraine is a common neurologic disorder characterized by attacks consisting of unilateral, throbbing headache accompanied by photophobia, phonophobia, and nausea which remarkably reduces the patients’ quality of life. Not migraine-specific non-steroidal anti-inflammatory drugs (NSAIDs) are effectiv...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Scuteri, Damiana, Adornetto, Annagrazia, Rombolà, Laura, Naturale, Maria Diana, Morrone, Luigi Antonio, Bagetta, Giacinto, Tonin, Paolo, Corasaniti, Maria Tiziana
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6465320/
https://ncbi.nlm.nih.gov/pubmed/31024319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00363
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars